WillItSurvive
Pharma and healthcare groups · Indonesia

Mitra Keluarga Karyasehat

mitrakeluarga.com ↗

Indonesian hospital chain running 31-33 private hospitals and 4,160+ beds.

Hard to displace
Assessed 26 July 2026 · Evidence as of 26 July 2026
Strong structural protection; the business model survives ai pressure.
On the recordSince 26 July 2026 · Checkable from 31 Jul 2026 · Every call on the record Checkpoint: Q2 2026 earnings release, first full read on margins after private-pay mix hit 89%
The call

Mitra keeps growing profit by shifting toward richer private-pay patients even as total patient volume falls, a trade that works only as long as that mix has room left to shift.

Mitra Keluarga Karyasehat runs hospitals in Indonesia and makes money by serving wealthy patients who can pay out of pocket, rather than relying on government insurance. It is hard to copy because building hospitals costs huge amounts of money, requires government permission, and takes years to recruit good doctors. The public hospital system cannot compete with it because the government does not give public hospitals enough money to offer fancy private care. The one thing to watch: the company added more private-pay patients this year and grew revenue, but the number of total patients actually fell. If it keeps losing patients after running out of wealthy customers to convert, it will only be able to grow by charging higher prices instead of seeing more people, which is weaker long-term.

Why
01
AI pressure: AI telehealth and diagnostic apps like Halodoc and Alodokter. AI apps route common ailments to cheap virtual consults, but surgery, ICU care, and inpatient stays still need Mitra's physical hospitals. Could AI do the core job? Unlikely.
02
Bigger players: Siloam Hospitals Group. Siloam and Hermina run competing private hospital networks across Indonesia, chasing the same premium private-pay patients. Could a giant copy it? No, they are blocked.
03
What protects it. New hospitals take years and capital to build, and 95% doctor retention keeps referral networks tied to Mitra's facilities.
What would change this call
MIKA reports patient volume trend in Q2 2026 earnings (due ~31 Jul 2026). Continued volume decline after 89% private-pay saturation would show growth is price-only, not share gain.
Siloam or Hermina report same-hospital revenue/bed-count growth outpacing MIKA in 2026. Would indicate patients are moving to competitors rather than overall market growth.
Indonesian government announces mandate raising BPJS patient quotas at private hospitals. Would compress MIKA's private-pay margin premium and its core moat.
Key numbers
  • 9M2025 revenue up 10.0% YoY, net income up 15.6% (2025-12-09)
  • Private-pay revenue hit 89% of total by Q1 2026 (2026-07-02)
  • Doctor retention rate 95% in 1H2025 (2025-08-22)
Named risks
  • Government mandate forcing higher BPJS volume at capped rates could compress private-pay margin premium. Severity: high
  • Patient volume declined 6.8% YoY in 1H2025 even as revenue rose via mix shift, limiting organic growth. Severity: medium
  • Larger private peers Siloam and Hermina expanding faster, pressuring competitive position. Severity: medium
  • IDX flagged MIKA for unusual market activity twice (Dec 2024, Mar 2025), signaling trading irregularity risk. Severity: medium
  • Market cap reported down ~38.6% YoY by one tracker as of July 2026, indicating investor sentiment volatility. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
Siloam International Hospitals (SILO)losing toSiloam market cap ~Rp27.3T vs MIKA's ~Rp23.6-24.4T as of July 2026
Medikaloka Hermina (HEAL)contestingHermina operates 52 hospitals, market cap ~Rp12.7T as of Dec 2024, closing gap on MIKA
Indonesia's public hospital systemgaining onPublic hospitals hold ~51.4% national share but are budget-locked out of premium private-pay care (2024 study)
Famon Awal Bros Sedaya (PRAY)contestingMarket cap ~Rp10.4T as of July 2026, smaller listed private peer
Questions people ask
Is Mitra Keluarga Karyasehat (MIKA) profitable?
Yes. For the nine months ending September 2025, MIKA reported net income of Rp1.08 trillion, up 15.6% year over year, on revenue of Rp3.98 trillion, giving a net margin of roughly 27.2%, per its December 2025 investor summary.
Could AI replace Mitra Keluarga's hospitals?
No. MIKA delivers licensed inpatient and surgical care in physical hospitals with a 95% doctor retention rate as of August 2025. AI can assist admin and imaging workflows, but cannot substitute for licensed, in-person hospital treatment.
Who owns Mitra Keluarga Karyasehat?
PT Griyainsani Cakrasadaya is the controlling shareholder, holding roughly 64.65% of MIKA as of June 2026, and it added 400,000 shares in March 2025, signaling continued insider confidence.
Who is Mitra Keluarga's biggest competitor?
Siloam International Hospitals (SILO) is the larger rival, with a market cap of about Rp27.3 trillion versus MIKA's roughly Rp23.6-24.4 trillion as of July 2026, making Siloam Indonesia's largest listed private hospital chain.
Is patient volume growing at Mitra Keluarga?
No. Overall patient volume fell 6.8% year over year in 1H2025, even as revenue rose 4.5% to Rp2,563.46 billion, because the company shifted mix toward higher-paying private patients, per its August 2025 earnings presentation.
Is Mitra Keluarga stock rising or falling?
Mixed signals: market cap was about Rp23.6-24.4 trillion in July 2026, down roughly 38.6% year over year per one tracker, while the company announced a share buyback in March 2026 and was flagged twice for unusual market activity by IDX (December 2024, March 2025).
Timeline
  • 2026-07-02Q1 2026: revenue Rp1.36T (+6.6% YoY), EBITDA margin 37.6%, private-pay share hits 89%
  • 2026-06-10Griyainsani Cakrasadaya confirmed holding ~64.65% controlling stake
  • 2026-03-09MIKA announces planned share buyback
  • 2025-12-099M2025 results: revenue Rp3.98T (+10.0% YoY), net income Rp1.08T (+15.6% YoY)
  • 2025-08-221H2025 results: revenue +4.5% YoY despite patient volume down 6.8% YoY
  • 2025-06-26Sumber Kasih and Lemahabang Kasih hospitals opened
  • 2025-03-24IDX places MIKA on Unusual Market Activity watch list (second time)
  • 2025-03-01Griyainsani Cakrasadaya acquires 400,000 additional MIKA shares
  • 2024-12-23IDX places MIKA on Unusual Market Activity watch list (first time)
  • 2015-03-24PT Mitra Keluarga Karyasehat Tbk IPOs on Indonesia Stock Exchange as MIKA
Revision history
26 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Vertex PharmaceuticalsTenet HealthcareIntuitive Surgical
More in Pharma and healthcare groups →
Sources